InvestorsHub Logo
Followers 15
Posts 1049
Boards Moderated 0
Alias Born 04/07/2014

Re: scalpel post# 66820

Saturday, 02/17/2018 2:04:46 PM

Saturday, February 17, 2018 2:04:46 PM

Post# of 140464
Scalpel,

I respect your opinion but I think you are missing my point and then deflecting by saying I should just sell my shares if I criticize management. I think after seven years involvement with this stock I have the right to point out obvious inconsistencies in statements made in investor updates. I am also not going to take a substantial loss on almost 600,000 shares and have no choice to hold and hope something comes out of this after upcoming dilution and R/S.
I am sure the carefully crafted statements in November regarding performance of the “system” were true. My contention is that important issues that were already clearly identified by surgeons such as Dr. Estape were omitted. As I pointed out Dr. Estape said they identified the docking issue on the first cases they did. The PR for those cases came out Sept 25th, two months ahead of Nov update.
Do you honestly believe the docking issue and the laundry list of upgrades that need to be done were all identified in Dec and early Jan? IMO that is simply not credible.
If FDA was truly still on track for 2018 as of November with such glowing feedback and 6 plus months ahead before they would need more cash why did they do a double raise that diluted pps more than it would have at higher pps if they truly thought the feedback over the next 6 months out of clinical sites would be positive. Upward pps going into update with six months to run should have also brought .50 Warrants into play providing additional funds.
Sorry, IMO management knew in Nov delay was coming and that is why they wanted cash in bank before they disclosed the delay in carefully orchestrated white paper and then Feb update. I'm sorry if some want this to be a Facebook page where every agrees but I post positive messages when due and criticism when appropriate.

BelizeMe